Clinical trial
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected…
NCT00144248 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00144248 |
|---|---|
| Title | A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions |
| Official title | A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatic Insufficiency |
| Intervention type | Drug |
| Interventions | nevirapine |
| Enrollment | 51 |
| Start date | Jun 25, 2004 |
| Primary completion | Jun 1, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Dec 1, 2023 |
| Countries | France, Spain, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: